subject: Osteoporosis Chemical | Osteoporosis Drugs | Osteoporosis Product | Osteoporosis Manufacturers [print this page] Osteoporosis is a disease of bone that leads to an increased risk of fracture. In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of proteins in bone is altered. Osteoporosis is defined by the World Health Organization (WHO) in women as a bone mineral density 2.5 standard deviations below peak bone mass (20-year-old healthy female average) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture.
Profile :
Euroasian Chemicals Pvt. Ltd. evolved from Euroasia's group. The latter in the recent past has made its presence felt in the international market by the many specialization of drug discovery
Continued recognition and success coupled with a desire to serve the research community more efficiently has encouraged us to further diversify our services. We have dedicated R & D team comprising of organic chemists, biochemists, cell biologists, pharmacologists and molecular biologists. Our CRO's in the United States and China are an asset to our growing success.
Based in India, the world's outsourcing hub popular for its high quality and cost effective services, stable government and English speaking talent pool, Euroasian looks ahead with confidence in serving the very potential market that appears before it.
For more information on OSTEOPOROSIS Drugs Products Manufacturers Exporters Suppliers, please visit :
